Eye and Vision Disorders
Periocular Lesions
Urgent/Emergent
Preseptal/orbital cellulitis
Herpes zoster
Common
Affecting sebaceous glands: Blepharitis, stye, chalazion
Papular/nodular: Milia, xanthelasma, skin tag (acrochordons), seborrheic keratosis
Malignant: Basal cell carcinoma, squamous cell carcinoma
Additional considerations
Allergic reaction: Atopic dermatitis, urticaria +/- angioedema
Autoimmune: Heliotrope rash, vitiligo
Infectious: Verrucous lesions, molluscum
Red Eye
Differential Diagnosis
Trauma: Emergent ophthalmology referral in cases of moderate/severe pain, decreased visual acuity
Corneal abrasion
Foreign body
Chemical exposure
Vision changes: Emergent ophthalmology referral, especially if associated with pain
Keratitis
Corneal inflammation due to infection (bacteria, HSV, VZV, EBV, CMV), contact lenses, or corneal abrasion
Symptoms: Painful diminished vision +/- photophobia, foreign body sensation, mucopurulent discharge
Fluorescein/Wood’s lamp: Eyelid edema, hypopyon (leukocytes in anterior chamber), corneal ulcer
Iritis
Iris infection/inflammation due to perforating wound, corneal ulcer, or certain autoimmune conditions
Acute onset (hours) eye pain radiating to forehead/temple, diminished/blurred vision, photophobia
Eye watering/redness, ciliary/perilimbal injection, constricted/sluggish pupils
Acute angle-closure glaucoma
Obstructed aqueous humor outflow resulting in increased intraocular pressure
Acute onset severe/throbbing pain, diminished vision, light halos
Diffuse eye redness/watering, decreased visual acuity, pupil dilation with decreased reactivity to light, eye pain/firmness with palpation
Non-emergent
Blepharitis: Inflammatory condition of eyelid margins
Conjunctivitis (most common)
Allergic: Azelastine 0.05% (H1 receptor antagonist) 1 drop q12h
Keratoconjunctivitis (dry eye): Review history (Sjogren risk factors), medications (anticholinergic, antihistamine, OCPs) and consider trial of artificial tears
Viral: Symptomatic treatment
Bacterial: Erythromycin 0.5%, apply 0.5 inch long ribbon q6h x 7 days
Subconjunctival hemorrhage: Benign and resolve spontaneously
Episcleritis: Episcleral inflammation often associated with autoimmune disease (e.g. rheumatoid arthritis)
Generally self-limited with resolution in 3 weeks
Consider topical steroids for severe cases
Red Eye Ophthalmology Referrals
Emergent
Mechanism: Acute eye trauma
Symptoms
Moderate to severe pain
Acute vision loss: Associated with recent ocular surgery or concern for keratitis, iritis, acute angle closure glaucoma
Physical Exam
Vesicular rash (herpetic keratitis)
Severe mucopurulent discharge (hyperacute bacterial conjunctivitis)
Evidence corneal involvement with fluorescein/Wood's lamp
Distorted pupil
Non-emergent
History of recurrent eye infections or episcleritis episodes
Exam: Copious purulent discharge not improving with antibiotics
Treatment
Pain not relieved with topical anesthetic
Indication for starting topical steroids (e.g. severe episcleritis)
Vision Abnormalities/Loss
Adult
Acute: Require emergent evaluation by ophthalmology
Trauma: Physical and chemical injuries
Acute angle closure glaucoma
Retinal tear/detachment
Retinal vascular occlusion
Risk factors: HTN, DM
Sudden, painless visual loss
Tortuous, dilated retinal veins on fundoscopic exam +/- cotton wool spots, afferent pupillary defect on affected side
Optic nerve disease
Additional resource: Vision Loss in Older Persons, Fig. 2
Chronic
Emergent: Temporal (giant cell) arteritis
Epidemiology: Most common ages 70 - 79 years in patient with history of polymyalgia rheumatica
Presentation: Age > 50 years with new onset unilateral headache/visual disturbances +/- jaw claudication, fever, anemia, elevated ESR and/or CRP
Start prednisone 1 mg/kg (maximum 60 mg/day) q24h
Refer for color doppler ultrasonography vs. temporal artery biopsy (gold standard)
Consider additional screening for thoracic and abdominal aortic aneurysms due to increased risk
Age-related cataracts (most common)
Age > 40 years
Vision loss associated with glare intolerance/halos worse at night or while driving
Refer for surgical intervention when affecting activities of daily living
Diabetic retinopathy
Age > 50 years and more common in Hispanics
Fluctuating vision with floaters, light flashes, visual field deficits
Tight glycemic control, fenofibrate, panretinal photocoagulation
Glaucoma
Age > 40 years and more common in African Americans
Progressive peripheral and central field visual loss
Lower intraocular pressure with medicated eye drops vs. laser trabeculoplasty
Macular degeneration
Vision loss worse at night with positive Amsler grid test
Macular drusen and retinal pigment abnormalities
Slow progression with
Smoking cessation
AREDS2 vitamin supplementation to slow progression: Vitamin C 500 mg, vitamin E 400 IU, 25 mg zinc, 2 mg cupric oxide, 10 mg lutein, 2 mg zeaxanthin (e.g. PreserVision)
VEGF injections e.g. bevacizumab (Avastin) for neovascular subtype
Pediatric
Acute: Emergent consultation for trauma, orbital cellulitis, central retinal artery occlusion, and endophthalmitis
Painful
Trauma: Globe rupture, corneal injury, hyphema, lens dislocation, vitreous hemorrhage, retinal detachment, optic nerve injury
Surrounding skin changes: Orbital cellulitis
Red eye
Normal IOP: Keratoconjunctivitis (HSV vs. adenovirus)
Endophthalmitis (internal eye infection): Emergent consultation for possible intravitreal treatment and/or vitrectomy
Uveitis
Otherwise normal appearance
Painful EOM: Optic neuritis
Painless EOM: Ocular migraine
Painless
Leukorrhea present: Cataract vs. intraocular tumor
Retinal detachment/hemorrhage: Evaluate for child abuse
Central retinal artery occlusion: Consider in children with sickle cell disease
Optic migraine (non-emergent)
Chronic
Strabismus: Risk factor for visual loss
Unequal alignment and may be esotropic (adduction) or exotropic (abduction)
High risk for visual loss (see amblyopia)
Refer to pediatric ophthalmology with consideration for surgery if conservative treatment fails
Amblyopia
Reduction in visual acuity and may be strabismic (unequal alignment), refractive (unequal focus), or deprivational (structural abnormalities obscuring incoming image)
Treatment options: Patching, optical penalization, atropine eye drops